Viewing nowOkobastat Tablet 10mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

MFDS item code 201805136 · Approved 2018.12.18 · Insurance code 629701500
Improvement of dyslipidemia and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps reduce the risks of various cardiovascular diseases. It decreases the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease or type 2 diabetes, and also reduces the risks associated with vascular interventions and angina. Furthermore, in patients with clinical evidence, it lowers the risk of hospitalization due to myocardial infarction, stroke, angina, and congestive heart failure. This medication improves total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels in the treatment of hyperlipidemia, and plays a role in increasing HDL cholesterol levels. It is particularly used as an adjunct treatment in various types of dyslipidemia patients who do not respond to dietary interventions and in children with familial hypercholesterolemia. This medication is widely used to improve cardiovascular health and reduce risk factors.
Patients taking atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg only when a reduction in LDL cholesterol of 45% or more is required). This medicine is administered at doses ranging from 10 to 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed 2–4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use at the start of treatment and to evaluate response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia Administer this medicine at a dose of 10–80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Older adults: Efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10–17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
Treatment should be discontinued immediately if there are abnormal muscle symptoms. There is a risk of serious muscle diseases such as myopathy or rhabdomyolysis, so consult a doctor if these symptoms occur. This medication should not be used in individuals with allergic reactions or severe liver dysfunction, women who are pregnant or breastfeeding, and children under 10 years of age. Patients with compromised liver or kidney function, alcohol dependence, hypothyroidism, and elderly patients who are at high risk for muscle abnormalities should use this medication cautiously and require regular check-ups. If any allergic symptoms, such as liver dysfunction, skin rash, hives, or difficulty breathing, appear while using this medication, inform a physician immediately. This medication may interact with other drugs, especially if taken with certain antibiotics, antifungals, antivirals, and other lipid-lowering agents, so caution is needed, and consultation with a doctor or pharmacist is recommended. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age must use appropriate contraception while on this medication. Elderly patients or those with diminished renal function are at higher risk for muscle abnormalities, so they should be carefully observed for symptoms such as muscle pain or weakness while on this medication. There is no specific detoxification method for overdose, so appropriate treatment should be administered based on symptoms, and liver function and muscle enzyme levels should be regularly checked. This medication should be stored out of reach of children and kept in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature. Proper storage will help to maintain the efficacy and safety of the medication for a longer time.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.